Interleukin-6 Deficiency Increases Inflammatory Bone Destruction
Open Access
- 1 February 2001
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (2) , 744-750
- https://doi.org/10.1128/iai.69.2.744-750.2001
Abstract
Periapical bone destruction occurs as a consequence of pulpal infection. In previous studies, we showed that interleukin-1 (IL-1) is the primary stimulator of bone destruction in this model. IL-6 is a pleiotropic cytokine that is induced in these infections and has both pro- and anti-inflammatory activities. In the present study, we determined the role of IL-6 in regulating IL-1 expression and bone resorption. The first molars of IL-6 knockouts (IL-6−/−) and wild-type mice were subjected to surgical pulp exposure and infection with a mixture of four common pulpal pathogens, includingPrevotella intermedia,Fusobacterium nucleatum,Peptostreptococcus micros, andStreptococcus intermedius. Mice were killed after 21 days, and bone destruction and cytokine expression were determined. Surprisingly, bone destruction was significantly increased in IL-6−/−mice versus that in wild-type mice (by 30%;P< 0.001). In a second experiment, the effects of chronic (IL-6−/−) IL-6 deficiency and short-term IL-6 deficiency induced by in vivo antibody neutralization were determined. Both IL-6−/−(30%;P< 0.001) and anti-IL-6 antibody-treated mice (40%;P< 0.05) exhibited increased periapical bone resorption, compared to wild-type controls. The increased bone resorption in IL-6-deficient animals correlated with increases in osteoclast numbers, as well as with elevated expression of bone-resorptive cytokines IL-1α and IL-1β, in periapical lesions and with decreased expression of the anti-inflammatory cytokine IL-10. These data demonstrate that endogenous IL-6 expression has significant anti-inflammatory effects in modulating infection-stimulated bone destruction in vivo.Keywords
This publication has 53 references indexed in Scilit:
- B-Cell Deficiency Predisposes Mice to Disseminating Anaerobic Infections: Protection by Passive Antibody TransferInfection and Immunity, 2000
- Expression of Inflammatory Cytokine Genes In Vivo by Human Alveolar Bone-Derived Polymorphonuclear Leukocytes Isolated from Chronically Inflamed Sites of Bone ResorptionCalcified Tissue International, 1996
- THE ROLE OF IL-4 AND IL-6 IN IL-1-DEPENDENT CARTILAGE MATRIX DEGRADATIONRheumatology, 1995
- The Role of Interleukin-6 in Mucosal IgA Antibody Responses in VivoScience, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- The acute phase responseImmunology Today, 1994
- Long-Term Consequences of Interleukin-6 Overexpression in Transgenic MiceDNA and Cell Biology, 1992
- Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblatsBiochemical and Biophysical Research Communications, 1990
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989